New Drug Treats Lung, Thyroid Cancer

[vocalEK]

This is interesting: medpagetoday.com/hematology...

"WASHINGTON -- The FDA approved selpercatinib (Retevmo) as the first specific treatment for metastatic non-small cell lung cancer (NSCLC) or thyroid cancer with rearranged during transfection (RET) gene fusions.

A selective inhibitor of the RET kinase, selpercatinib received the indication through FDA's accelerated approval process, which requires the sponsor, Eli Lilly, to conduct additional studies to confirm the safety and efficacy of the drug as a condition of final approval."

[helvella Administrator]

I am sorry that you do not appear to have received a timely response to your post/question - or perhaps you got an answer on another post or in a Private Message? Please feel free to post a new question if you wish. Posts are sometimes missed as it is so busy. Or maybe no-one who read it was able to answer?

Please do not feel the need to respond.